Purification and identification of intestinal mucosal cell proliferation-promoting peptides from Crassostrea hongkongensis
- 33 Downloads
Oyster peptides, together with polysaccharides, were found to protect the intestinal mucosal barrier against the harmful effects of 5-FU chemotherapy on rats in our previous study. However, whether oyster (Crassostrea hongkongensis) peptide can promote intestinal epithelia cell proliferation and migration alone is unknown. In this paper, oyster tissue was hydrolyzed using pepsin, trypsin, papain, bromelain, neutrase, flavorzyme, and alcalase protease. Among the hydrolysates that produced by trypsin showed the highest promoting effect on intestinal epithelia cell (IEC-6) proliferation and was fractionated into three molecular weight ultra-filtrates of > 10, 10–5, and < 5 kDa. The 10–5 kDa ultra-filtrate showed the highest promoting effect on cell proliferation, at 146.16 ± 6.56% (0.16 mg/ml), and was subjected to further purification. Two oyster peptides (F3-1 and F3-2) were purified from the 5–10 kDa ultra-filtrate by SEC and RP-HPLC. Their molecular mass and amino acid sequences were identified as VAPEEHPVLL (MW, 1102.5872 Da) and SYELPDGQVITIGNER (MW, 1789.9247 Da) by MALDI–TOF–MS/MS. Peptides F3-1 and F3-2 exhibited 150.81 ± 12.34% (5 µg/ml) and 151.73 ± 12.28% (6.25 µg/ml) promoting effects on IEC-6 proliferation, respectively, and both peptides showed greater promoting effects than the positive control (proglumide) at the same concentration under LPS stimulation culture conditions. This study indicated that oyster peptides could serve as a potential source of a functional food constituent for intestinal epithelium protection.
KeywordsPeptides Crassostrea hongkongensis Cell proliferation promotion Cell migration promotion Intestinal epithelia
We thank Dr. Yongli Gao, Shikun Dai, and Xiangyu Qin (the Equipment Public Service Center, SCSIO.CAS) for assistance in the ultra-centrifuge and mass spectrometric analyses. Our work is supported by grants from National Key R&D Program of China (No. 2018YFC0311200), Natural Science Foundation of Guangdong Province, China (No. 2018A030313088, 2018A030313903, 2018A0303130144 and 2018A030313626), the Project of Public Science and Technology Research Funds Projects of Ocean (No. 201305018), Science and Technology Program of Guangzhou, China (201707010164), the Science and Technology Planning Project of Guangdong Province, China (Nos. 2013B090800002 and 2015B090904003) and Pearl River S&T Nova Program of Guangzhou (201710010095).
Compliance with ethical standards
Conflict of interest
All the authors declare that they have no conflicts of interest.
Compliance with ethics requirements
The research has fully complied with research ethics.
- 9.Joo E, Yamane S, Hamasaki A, Harada N, Matsunaga T, Muraoka A, Suzuki K, Nasteska D, Fukushima T, Hayashi T, Tsuji H, Shide K, Tsuda K, Inagaki N (2013) Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice. Nutrition 29(3):549–555CrossRefGoogle Scholar
- 12.Lin JF, Sun ZR, Zhang W, Liu HM, Shao DB, Ren Y, Wen YF, Cao LP, Wolfram J, Yang ZZ, Nie SN (2015) Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Mol Cell Biochem 404(1–2):263–270CrossRefGoogle Scholar
- 14.Yi HB, Yu CH, Zhang HW, Song DG, Jiang DH, Du HH, Wang YZ (2015) Cathelicidin-BF suppresses intestinal inflammation by inhibiting the nuclear factor-kappa B signaling pathway and enhancing the phagocytosis of immune cells via STAT-1 in weanling piglets. Int Immunopharmacol 28(1):61–69CrossRefGoogle Scholar
- 16.Tang XP, Liu H, Yang SF, Li ZH, Zhong JF, Fang RJ (2016) Epidermal growth factor and intestinal barrier function. Mediat Inflamm 1927348. https://doi.org/10.1155/2016/1927348